iDOVE: Durability of Vaccine Efficacy Against SARS-CoV-2 Infection (original) (raw)
Implements a nonparametric maximum likelihood method for assessing potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection under staggered enrollment and time-varying community transmission, allowing crossover of placebo volunteers to the vaccine arm. Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021) <doi:10.1093/cid/ciab630>.
| Version: | 1.5 |
|---|---|
| Depends: | R (≥ 3.5.0) |
| Imports: | Rcpp (≥ 1.0.4.6), methods, stats, graphics, RcppArmadillo |
| LinkingTo: | Rcpp, RcppArmadillo |
| Suggests: | rmarkdown, knitr |
| Published: | 2023-12-13 |
| DOI: | 10.32614/CRAN.package.iDOVE |
| Author: | Yu Gu [aut], Shannon T. Holloway [aut, cre], Dan-Yu Lin [aut] |
| Maintainer: | Shannon T. Holloway <shannon.t.holloway at gmail.com> |
| License: | GPL-2 |
| NeedsCompilation: | yes |
| Materials: | |
| CRAN checks: | iDOVE results |
Documentation:
Downloads:
Linking:
Please use the canonical formhttps://CRAN.R-project.org/package=iDOVEto link to this page.